Opinions Julien Nono-Womdim
LiquidiaLQDATOP PICKJul 21, 2026
Julien Nono-WomdimOwned
$80.26
Stock price when the opinion was issued
$86.22
As of Jul 24, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
A small company involved in a rare lung disease, PAH. He made money off a similar situation in United Therapeutics, but LQDA has a better drug that is taking share from UT. So, he switched horses.
(Analysts’ price target is $53.75)
Gordon ReidOwned
biotechnologypharmaceutical
The addressable market is $5 billion. LQDA has a superior offering to United Therapeutics. Trades at 10x 2028 PE, which is expensive for a blockbuster drug. They are in a lawsuit with United over a drug, but despite that, LQDA is a top pick.
(Analysts’ price target is $74.25)